drugset / Trial / NCT02622230
Tolerability, Safety and Pharmacokinetic Study Of Mianhuahua Flavonoids Tablets in Healthy Adult Subjects
Phase 1
Unknown
60 enrolled
Xinjiang Uygur Pharmaceutical Co., Ltd.
Chinese Academy of Sciences · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine the safety and tolerability, and to evaluate the pharmacokinetic characteristics of Mianhuahua Flavonoids Tablets after oral administration in healthy adult subjects.
Timeline
- Start
- 2015-12
- Primary completion
- 2016-10
- Completion
- 2016-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mianhuahua Flavonoids Tablets | Unknown | 0.3 g | Oral |
| Subject | Mianhuahua Flavonoids Tablets | Unknown | 0.9 g | Oral |
| Subject | Mianhuahua Flavonoids Tablets | Unknown | 1.2 g | Oral |
| Subject | Mianhuahua Flavonoids Tablets | Unknown | 1.5 g | Oral |
| Subject | Mianhuahua Flavonoids Tablets | Unknown | 1.8 g | Oral |
| Subject | Mianhuahua Flavonoids Tablets | Unknown | 2.7 g | Oral |
| Subject | Mianhuahua Flavonoids Tablets | Unknown | 3.6 g | Oral |
| Subject | Mianhuahua Flavonoids Tablets | Unknown | 4.5 g | Oral |
| Subject | Mianhuahua Flavonoids Tablets | Unknown | 5.4 g | Oral |
Indications
No indication recorded.